PubRank

H T Wepsic

Author PubWeight™ 38.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Res 1987 1.59
2 Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. J Natl Cancer Inst 1970 1.27
3 Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunity. J Natl Cancer Inst 1970 1.14
4 Tumor-specific antigens detected by inhibition of macrophage migration. Science 1969 1.13
5 The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant 1992 1.04
6 Concurrent primary parathyroid hyperplasia and parathyroid carcinoma. Arch Pathol Lab Med 1983 0.98
7 Immunotherapy of cancer: an experimental model in syngeneic guinea pigs. Science 1970 0.98
8 Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes. J Natl Cancer Inst 1969 0.96
9 Rat alpha1 fetoprotein. IV. Effect of growth and surgical removal of Morris hepatoma 7777 on the serum alpha1F concentration of Buffalo rats. J Natl Cancer Inst 1974 0.94
10 Isolation and characterization of rat 1 -fetoprotein. Cancer Res 1972 0.93
11 Tumor immunity: impairment in tumor-bearing hosts. J Natl Cancer Inst 1971 0.93
12 Macrophages can recognize and kill tumor cells bearing the membrane isoform of macrophage colony-stimulating factor. Blood 1996 0.92
13 Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils. J Natl Cancer Inst 1970 0.91
14 Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity. J Natl Cancer Inst 1970 0.90
15 Alpha-fetoprotein: expression in human disease and in rat experimental models. Prog Exp Tumor Res 1974 0.89
16 Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway. J Immunol 1998 0.86
17 Systemic transfer of tumor immunity: delayed hypersensitivity and suppression of tumor growth. J Natl Cancer Inst 1970 0.86
18 Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor. Mol Ther 2001 0.86
19 Inhibition of the graft-versus-host response by BCGcw-induced suppressor cells or prostaglandin E1. Cell Immunol 1983 0.85
20 Antigenic specificity of hepatomas induced in strain-2 guinea pigs by diethylnitrosamine. J Natl Cancer Inst 1969 0.83
21 Alpha-fetoprotein and its relevance to human disease. Gastroenterology 1979 0.82
22 Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cells. J Natl Cancer Inst 1971 0.82
23 Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells. Cancer Res 1987 0.81
24 Overview of oncofetal antigens in cancer. Ann Clin Lab Sci 1983 0.81
25 Stimulation of prostaglandin-dependent macrophage suppressor cells by the subcutaneous injection of polyunsaturated fatty acids. Cell Immunol 1986 0.81
26 Characterization of growth properties and demonstration of the tumor-specific transplantation antigens of Morris hepatomas. Cancer Res 1976 0.81
27 Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor. J Immunol 1999 0.81
28 Macrophage colony stimulatory factor-activated bone marrow macrophages suppress lymphocytic responses through phagocytosis: a tentative in vitro model of Rosai-Dorfman disease. J Leukoc Biol 1995 0.80
29 Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice. Cell Immunol 1987 0.80
30 Comparison of double-antibody radioimmunoassay with Farr-technique radioimmunoassay and double-antibody enzyme immunoassay for alpha-fetoprotein. Clin Chem 1977 0.79
31 Effect of horse antibody to rat alpha-fetoprotein upon the growth of AH-66 in Donryu rats. Int J Cancer 1980 0.79
32 Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall. Cancer Res 1984 0.79
33 Purification of specific antibody to alpha-foetoprotein and its immunological effect on cancer cells. J Chromatogr 1981 0.79
34 Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors. J Leukoc Biol 1987 0.78
35 The effects of E series prostaglandins on blastogenic responses in vitro and graft vs. host responses in vivo. Immunopharmacol Immunotoxicol 1988 0.78
36 BCG-induced macrophages as suppressor cells. Cancer Invest 1983 0.77
37 The effects of 16,16-dimethyl PGE2 and phosphodiesterase inhibitors on Con A blastogenic responses and NK cytotoxic activity of mouse spleen cells. J Leukoc Biol 1990 0.77
38 Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer. Mol Ther 2001 0.77
39 Prostaglandin E2 induces up-regulation of murine macrophage beta-endorphin receptors. Immunol Lett 1995 0.76
40 Detection of interleukin 2 receptors on murine lymphocytes using fluorescent interleukin 2. Immunol Lett 1993 0.76
41 Enhancement of tumor growth following immunization with Bacillus Calmette-Guérin cell walls. Cancer Res 1976 0.76
42 Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses. Clin Exp Immunol 1984 0.76
43 Alpha(1)-fetoprotein. West J Med 1975 0.75
44 Effects of drugs on different types of synovial inflammation in the rabbit. Yale J Biol Med 1968 0.75
45 Growth of transplanted rat tumors following administration of cell-free tumor antigens. Cancer Res 1978 0.75
46 The identification of the neonatal NBXFO hybridoma cell and its mediator. Dev Comp Immunol 1996 0.75
47 Bacillus Calmette-Guérin cell wall immunotherapy of intramuscular and metastatic Morris rat hepatomas. Cancer Res 1978 0.75
48 Hematopoietic colony stimulatory factor formation by murine mesangial cells: gene expression and biological activity. Biochim Biophys Acta 1994 0.75
49 The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors. Exp Hematol 1988 0.75
50 Alpha-fetoprotein levels in amniotic fluid and maternal serum as determined by radioimmunoassay: implications for prenatal diagnosis of fetal neural tube defects. Birth Defects Orig Artic Ser 1977 0.75
51 Alpha-1-fetoprotein in a patient with a poorly differentiated carcinoma of the anterior mediastinum. Cancer 1976 0.75
52 Rat alpha1F. XI. Immunological control of cell proliferation: increased growth rate and alpha1F production by Morris hepatoma 5123tc in rats treated with anti-thymocyte serum. Int J Cancer 1974 0.75
53 Antitumor therapeutic effect of neurotropin on transplanted tumors in rats. Oncology 1984 0.75
54 Stimulation of hematopoiesis and bone marrow suppressor cells by the subcutaneous injection of linoleic acid. Cell Immunol 1987 0.75
55 The inhibition of fatal graft-versus-host disease by immunization of donor or host with bacillus Calmette-Guérin cell walls. Transplantation 1984 0.75
56 Detection of a membrane-associated cytokine (macrophage colony stimulating factor) using a modified commercially available ELISA. Biotechniques 1996 0.75
57 Macrophages that kill glioma cells expressing the membrane form of macrophage colony stimulating factor are resistant to prostaglandin E2 and interleukin-10. Immunol Lett 1999 0.75
58 Alpha-1-fetoprotein and alcoholic hepatitis. Am J Dig Dis 1974 0.75
59 Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis. J Immunopharmacol 1986 0.75
60 Identification and characterization of the BCG cell wall-stimulated suppressor cells in inbred rats. Oncodev Biol Med 1982 0.75
61 Characterization of serum protein components from Donryu rats which were immune to hepatoma AH-66 tumor cells. Jpn J Exp Med 1982 0.75
62 Modification of in vitro and in vivo BCG cell wall-induced immunosuppression by treatment with chemotherapeutic agents or indomethacin. J Natl Cancer Inst 1985 0.75
63 Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor. Int Immunopharmacol 2001 0.75
64 The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels. UCLA Forum Med Sci 1978 0.75